The Division of Medical Oncology is pleased to announce that David Carbone, MD, an internationally renowned lung cancer expert, has recently joined Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute. He is a professor in the Division of Medical Oncology and will be developing and leading a new thoracic oncology center. The thoracic oncology center will bring physicians and scientists together to develop new and targeted approaches to treating and curing lung cancer.
Dr. Carbone is an expert in the molecular genetics of lung tumors, which includes understanding the cells and genetic markers in each patient’s lung cancer and developing treatments and drugs that target specific tumor cells. He comes to the OSUCCC – James from Vanderbilt University, where he was a professor of medicine and cancer biology. He directed the Experimental Therapeutics Program and then the Thoracic and Head & Neck Cancer Program at the Vanderbilt-Ingram Cancer Center. In addition, he led the Thoracic Oncology Center at Vanderbilt.
Dr. Carbone’s research interests, grant support and publications focus on lung cancer, specifically genetics, immunotherapy, tumor-associated immunosuppression mechanisms and gene therapy. His lab team’s recent research includes molecular profiling of lung cancers and pre-neoplasias, especially the use of mass spectrometry-based proteomics. Dr. Carbone has authored more than 200 peer-reviewed publications and review articles. He has also served on several National Cancer Institute (NCI) grant review panels.
Dr. Carbone earned his medical degree and a PhD in molecular biology and genetics in 1985 from Johns Hopkins University, where he also completed his internal medicine internship and residency. He completed a medical oncology fellowship at the NCI. Dr. Carbone next joined the faculty at the University of Texas Southwestern Medical Center, where he stayed for five years before going to Vanderbilt in 1996.